Cleveland Biolabs (CBLI) Reports Q3 Loss of $0.31
Tweet
Share
E-mailGet Alerts CBLI Hot Sheet
Price: $3.17 --0%
Financial Fact:
Total operating expenses: 1.86M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total operating expenses: 1.86M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Cleveland Biolabs (NASDAQ: CBLI) reported Q3 EPS of ($0.31), versus $1.43 reported last year. Revenue for the quarter came in at $501 thousand, versus $415 million reported last year.
For earnings history and earnings-related data on Cleveland Biolabs (CBLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- CoStar Group acquires Zonda for $800M, adding new home data
- The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
